MYASTHENIA GRAVIS - AN AUTOIMMUNE RECEPTOR DISEASE-
- 29 January 2009
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 65 (S90) , 112-121
- https://doi.org/10.1111/j.1600-0404.1982.tb03410.x
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- CLINICAL, PATHOLOGICAL, HLA ANTIGEN AND IMMUNOLOGICAL EVIDENCE FOR DISEASE HETEROGENEITY IN MYASTHENIA GRAVISBrain, 1980
- Immunological Studies on Human ThymusActa Medica Scandinavica, 1980
- Pharmacokinetics and oral bioavailability of pyridostigmine in manEuropean Journal of Clinical Pharmacology, 1980
- SIGNIFICANCE IN NEONATAL MYASTHENIA GRAVIS OF INHIBITORY EFFECT OF AMNIOTIC FLUID ON BINDING OF ANTIBODIES TO ACETYLCHOLINE RECEPTORThe Lancet, 1979
- Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- A pharmacokinetic study of neostigmine in man using gas chromatography-mass spectrometryEuropean Journal of Clinical Pharmacology, 1979
- The Value of Thymectomy in Myasthenia GravisAnnals of Surgery, 1976
- IMMUNOPEROXIDASE LOCALIZATION OF ALPHA BUNGAROTOXIN: A NEW APPROACH TO MYASTHENIA GRAVIS*Annals of the New York Academy of Sciences, 1976
- Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.BMJ, 1975
- Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine ReceptorsScience, 1974